Weekly Recap: Q2 BD COR high—throughput installs and Goldman Sachs $515 target

Waters Corporation (NYSE:WAT) is accelerating Q2 momentum with 15 BD COR high—throughput installs and plans to migrate more assays from BD MAX plus add an HPV home/self—test option, while Goldman Sachs reiterates a Buy and bumps its price target to $515.Previous Week RecapThis is an AI-generated su…